What are the perioperative American Diabetes Association (ADA) glycemic targets?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Perioperative ADA Glycemic Targets

The American Diabetes Association recommends a perioperative blood glucose target range of 100–180 mg/dL (5.6–10.0 mmol/L) within 4 hours of surgery. 1

Target Range Rationale

The 100–180 mg/dL target represents the most current ADA guidance from 2024 1, which updated from the previous 80–180 mg/dL range used in earlier guidelines 2, 3, 4. This shift reflects accumulating evidence that:

  • Tighter targets do not improve outcomes: Multiple reviews have consistently demonstrated that perioperative glycemic control stricter than 80–180 mg/dL does not improve surgical outcomes 5, 1
  • Increased hypoglycemia risk: Stricter targets are associated with significantly more hypoglycemic episodes without clinical benefit 5, 1, 6

Key Perioperative Management Points

Preoperative Optimization

  • A1C target for elective surgery: <8% (63.9 mmol/L) whenever possible 1
  • Perform preoperative cardiac risk assessment for patients with high ischemic heart disease risk, autonomic neuropathy, or renal failure 1

Medication Management on Day of Surgery

Critical medication adjustments:

  • SGLT2 inhibitors: Discontinue 3–4 days before surgery (mandatory to prevent euglycemic DKA) 1
  • Metformin: Hold on day of surgery 1
  • Other oral agents: Hold morning of surgery 1
  • Basal insulin: Give 75–80% of long-acting analog dose OR 50% of NPH dose 1
  • Insulin evening before surgery: Reduce by 25% to decrease hypoglycemia risk while maintaining target range 5, 1

Intraoperative Monitoring

  • Monitor blood glucose every 2–4 hours while NPO 1
  • Dose with short- or rapid-acting insulin as needed 1
  • Do not use CGM alone for glucose monitoring during surgery 1

Insulin Strategy for Noncardiac Surgery

Basal-bolus insulin is superior to sliding scale alone: In noncardiac general surgery patients, basal insulin plus premeal short- or rapid-acting insulin coverage has been associated with improved glycemic outcomes and lower rates of perioperative complications compared with correction-only insulin without basal coverage 5, 1. This represents a critical distinction—reactive sliding scale regimens alone are inadequate.

Important Caveats

GLP-1 receptor agonists: There are limited data on their safe use perioperatively, particularly regarding delayed gastric emptying risk 1. Exercise caution and consider holding, though specific guidance is evolving.

Avoid overly aggressive targets: The evidence is clear that attempting to achieve glucose levels below 80 mg/dL perioperatively increases harm without benefit 5, 1, 6. The 100–180 mg/dL range balances hyperglycemia-related complications (infection, mortality, length of stay) against hypoglycemia risk.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.